Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Prospective Observational Study of Community Urology Practices Applying Germline Genetic Testing for Prostate Cancer Patients (PROCLAIM)

NCT05447637 is registered in ClinicalTrials.gov with Invitae Corporation as lead sponsor.

NCT NCT05447637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05447637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Prospective Observational Study of Community Urology Practices Applying Germline Genetic Testing for Prostate Cancer Patients (PROCLAIM)
Lead sponsor
Invitae Corporation
Phase
Observational
Overall status
Completed
Start date
November 1, 2019
Completion date
May 31, 2022
Enrollment
1,000 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer